CSIMarket


Mersana Therapeutics inc.  (MRSN)
Other Ticker:  
 


 

Mersana Therapeutics inc.

MRSN's Financial Statements and Analysis



Mersana Therapeutics inc. narrowed II. Quarter net loss per share of $-0.55 compare to net loss per share of $-0.59 recorded in the same quarter a year ago and improved compare to net loss per share of $-0.59 realized in previous quarter.


II. Quarter
Earnings Per Share Revenues
$ -0.55 $  4 Mill
$+0.04     $+4M     +38845.45 %



Mersana Therapeutics's Revenue rose by 38845.45 % in II. Quarter (Jun 30 2022) year on year, to $4 million and advanced by 110.41 % sequentially.


Mersana Therapeutics is Expected to report next financial results on November 08, 2022.

More on MRSN's Income Statement



Mersana Therapeutics's in II. Quarter recorded net loss of $-52.219 million, an increase from net loss of $-40.913 million in II. Quarter a year ago.

Sequentially net loss advanced

More on MRSN's Growth

In II. Quarter company's net cash and cash equivalents decreased by $-95 million, capital expenditures fell by 97.30%, to $-1 millions compare to same quarter a year ago and fell by 99.70% from I. Quarter (Mar 31 2022).

More on MRSN's Cash flow Statement


Mersana Therapeutics inc. does not pay out common stock dividend.

In trailing twelve-month period Mersana Therapeutics inc. payed $ -1.37 cash per share, on a free-cash flow basis .

Book value fell by -20.39 % sequentially to $1.40 per share, -14.63% of net loss per share in trailing twelve-month period were subtructed from shareholder value.
Tangible Book value fell to $ 1.40 per share from $ 1.76.

Company issued 15.83 million shares or 19.80 % in II. Quarter.


More on MRSN's Dividends

 Market Capitalization (Millions) 707
 Shares Outstanding (Millions) 96
 Total Debt (Millions $) 25
 Revenue (TTM) (Millions $) 6
 Net Income (TTM) (Millions $) -194
 Cash Flow (TTM) (Millions $) -92
 Capital Exp. (TTM) (Millions $) -1
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -




Mersana Therapeutics inc. does not pay out common stock dividend.

In trailing twelve-month period Mersana Therapeutics inc. payed $ -1.37 cash per share, on a free-cash flow basis .

Book value fell by -20.39 % sequentially to $1.40 per share, -14.63% of net loss per share in trailing twelve-month period were subtructed from shareholder value.
Tangible Book value fell to $ 1.40 per share from $ 1.76.

Company issued 15.83 million shares or 19.80 % in II. Quarter.


More on MRSN's Balance Sheets

 Market Capitalization (Millions) 707
 Shares Outstanding (Millions) 96
 Total Debt (Millions $) 25
 Revenue (TTM) (Millions $) 6
 Net Income (TTM) (Millions $) -194
 Cash Flow (TTM) (Millions $) -92
 Capital Exp. (TTM) (Millions $) -1
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -


   



       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

EAC's Profile

Stock Price

EAC's Financials

Business Description

Fundamentals

Charts & Quotes

EAC's News

Suppliers

EAC's Competitors

Customers & Markets

Economic Indicators

EAC's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071